Paolo Mascagni

6.7k total citations
110 papers, 5.4k citations indexed

About

Paolo Mascagni is a scholar working on Molecular Biology, Spectroscopy and Immunology. According to data from OpenAlex, Paolo Mascagni has authored 110 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 19 papers in Spectroscopy and 14 papers in Immunology. Recurrent topics in Paolo Mascagni's work include Histone Deacetylase Inhibitors Research (30 papers), Protein Structure and Dynamics (18 papers) and Chemical Synthesis and Analysis (16 papers). Paolo Mascagni is often cited by papers focused on Histone Deacetylase Inhibitors Research (30 papers), Protein Structure and Dynamics (18 papers) and Chemical Synthesis and Analysis (16 papers). Paolo Mascagni collaborates with scholars based in Italy, United States and United Kingdom. Paolo Mascagni's co-authors include Charles A. Dinarello, Gianluca Fossati, Flavio Leoni, Koichi Takayama, N Qureshi, Britta Siegmund, Giamila Fantuzzi, William A. Gibbons, Leonid L. Reznikov and Andrea Zaliani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Paolo Mascagni

110 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paolo Mascagni Italy 39 3.7k 1.2k 668 469 449 110 5.4k
Shin‐ichi Ishii Japan 38 3.1k 0.8× 590 0.5× 860 1.3× 381 0.8× 332 0.7× 258 5.7k
Savvas N. Savvides Belgium 40 2.8k 0.8× 1.4k 1.2× 499 0.7× 518 1.1× 228 0.5× 123 5.3k
S C Silverstein United States 42 3.0k 0.8× 2.3k 2.0× 460 0.7× 337 0.7× 442 1.0× 60 7.3k
R. Reid Townsend United States 39 3.9k 1.0× 575 0.5× 446 0.7× 274 0.6× 423 0.9× 69 6.0k
Andreas Billich Austria 42 4.6k 1.2× 1.1k 0.9× 386 0.6× 420 0.9× 195 0.4× 131 6.8k
Brian C. Cunningham United States 33 4.4k 1.2× 936 0.8× 1.1k 1.6× 871 1.9× 213 0.5× 47 6.9k
Keiya Tada Japan 30 2.5k 0.7× 1.1k 0.9× 422 0.6× 348 0.7× 240 0.5× 186 5.3k
Gary D. Glick United States 36 4.2k 1.1× 1.6k 1.3× 329 0.5× 178 0.4× 274 0.6× 98 6.0k
Noelle S. Williams United States 45 4.3k 1.1× 994 0.9× 1.1k 1.7× 479 1.0× 209 0.5× 113 6.9k
Atsushi Takahashi Japan 39 4.0k 1.1× 1.2k 1.0× 1.1k 1.6× 423 0.9× 295 0.7× 215 6.5k

Countries citing papers authored by Paolo Mascagni

Since Specialization
Citations

This map shows the geographic impact of Paolo Mascagni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Mascagni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Mascagni more than expected).

Fields of papers citing papers by Paolo Mascagni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Mascagni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Mascagni. The network helps show where Paolo Mascagni may publish in the future.

Co-authorship network of co-authors of Paolo Mascagni

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Mascagni. A scholar is included among the top collaborators of Paolo Mascagni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Mascagni. Paolo Mascagni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marampon, Francesco, Flavio Leoni, A. Mancini, et al.. (2018). Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma. Journal of Cancer Research and Clinical Oncology. 145(2). 393–409. 29 indexed citations
2.
Angiolilli, Chiara, Pawel A. Kabala, Aleksander M. Grabiec, et al.. (2016). Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. Annals of the Rheumatic Diseases. 76(1). 277–285. 115 indexed citations
3.
Lewis, Eli C., Joachim Størling, Sif G. Rønn, et al.. (2011). The Oral Histone Deacetylase Inhibitor ITF2357 Reduces Cytokines and Protects Islet β Cells In Vivo and In Vitro. Molecular Medicine. 17(5-6). 369–377. 87 indexed citations
4.
Matalon, Shay, Brent E. Palmer, Marcel F. Nold, et al.. (2010). The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression on CD4+ T-Cells and Monocytes and is Superior to Valproic Acid for Latent HIV-1 Expression in Vitro. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(1). 1–9. 69 indexed citations
5.
Sun, Yaping, Y. Eugene Chin, Elizabeth Weisiger, et al.. (2009). Cutting Edge: Negative Regulation of Dendritic Cells through Acetylation of the Nonhistone Protein STAT-3. The Journal of Immunology. 182(10). 5899–5903. 112 indexed citations
6.
Faraco, Giuseppe, Maria Gloria Pittelli, Leonardo Cavone, et al.. (2009). Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo. Neurobiology of Disease. 36(2). 269–279. 118 indexed citations
7.
Shein, Na’ama A., Nikolaos Grigoriadis, Alexander Alexandrovich, et al.. (2009). Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury. The FASEB Journal. 23(12). 4266–4275. 83 indexed citations
8.
Glauben, Rainer, A Batra, Thomas Stroh, et al.. (2008). Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice. Gut. 57(5). 613–622. 86 indexed citations
9.
Glauben, Rainer, Arvind Batra, I Fedke, et al.. (2006). Histone Hyperacetylation Is Associated with Amelioration of Experimental Colitis in Mice. The Journal of Immunology. 176(8). 5015–5022. 230 indexed citations
10.
Gancia, Emanuela, Gianpaolo Bravi, Paolo Mascagni, & Andrea Zaliani. (2000). Global 3D-QSAR methods: MS-WHIM and autocorrelation. Journal of Computer-Aided Molecular Design. 14(3). 293–306. 20 indexed citations
11.
12.
Bravi, Gianpaolo, et al.. (1997). MS-WHIM, new 3D theoretical descriptors derived from molecular surface properties: A comparative 3D QSAR study in a series of steroids. Journal of Computer-Aided Molecular Design. 11(1). 79–92. 89 indexed citations
13.
Molinari, Henriette, Lucia Zetta, William A. Gibbons, et al.. (1996). The Solution Structure of the Immunodominant and Cell Receptor Binding Regions of Foot‐and‐mouth Disease Virus Serotype A, Variant A. Journal of Peptide Science. 2(2). 75–90. 3 indexed citations
14.
Galli, Grazia, Pietro Ghezzi, Paolo Mascagni, Fabrizio Marcucci, & Maddalena Fratelli. (1996). Mycobacterium tuberculosis heart shock protein 10 increases both proliferation and death in mouse P19 teratocarcinoma cells. In Vitro Cellular & Developmental Biology - Animal. 32(7). 446–450. 13 indexed citations
15.
Molinari, Henriette, Lucia Zetta, Giuseppe Melacini, et al.. (1996). The Solution Conformational Features of Two Highly Homologous Antigenic Peptides of Foot‐and‐mouth Disease Virus Serotype A, Variants A and USA, Correlate with their Serological Properties. Journal of Peptide Science. 2(2). 91–105. 5 indexed citations
16.
Fossati, Gianluca, Anthony Coates, Stephen E. Harding, et al.. (1995). Mycobacterium tuberculosis Chaperonin 10 Forms Stable Tetrameric and Heptameric Structures. Journal of Biological Chemistry. 270(44). 26159–26167. 25 indexed citations
17.
Chan, Edward K. L., et al.. (1995). Sequence and Structural Homologies Between Mycobacterium tuberculosis Chaperonin 10 and the MHC Class I/II Peptide Binding Cleft. Biochemical and Biophysical Research Communications. 211(1). 14–20. 4 indexed citations
18.
Legname, Giuseppe, Gianluca Fossati, Nicoletta Monzini, et al.. (1995). Heterologous expression, purification, activity and conformational studies of different forms of dianthin 30.. PubMed. 1(2). 61–8. 8 indexed citations
19.
Garcı́a-Echeverrı́a, Carlos, et al.. (1991). Conformational analysis of two cyclic disulfide peptides. Biopolymers. 31(7). 835–843. 8 indexed citations
20.
Pastore, Annalisa, Piero Andrea Temussi, Severo Salvadori, Roberto Tomatis, & Paolo Mascagni. (1985). A conformational study of the opioid peptide dermorphin by one-dimensional and two-dimensional nuclear magnetic resonance spectroscopy. Biophysical Journal. 48(2). 195–200. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shin‐ichi Ishii Breakdown of academic impact, for papers by Savvas N. Savvides Breakdown of academic impact, for papers by S C Silverstein Breakdown of academic impact, for papers by R. Reid Townsend Breakdown of academic impact, for papers by Andreas Billich Breakdown of academic impact, for papers by Brian C. Cunningham Breakdown of academic impact, for papers by Keiya Tada Breakdown of academic impact, for papers by Gary D. Glick Breakdown of academic impact, for papers by Noelle S. Williams Breakdown of academic impact, for papers by Atsushi Takahashi
Rankless by CCL
2026